Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study

Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study

Background/Objectives: Diabetic macular edema (DME) is a significant cause of visual impairment, often treated with anti-vascular endothelial growth factor (anti-VEGF) agents. However, some patients do not respond adequately to this treatment. This study aims to evaluate the contribution of the intr...

Full description

Bibliographic Details
Main Authors: Ferhat Turgut, Gábor M. Somfai, Christoph Tappeiner, Katja Hatz, Irmela Mantel, Aude Ambresin, Guy Donati, Viviane Guignard, Dana Nagyová, Isabel B. Pfister, Christine Schild, Justus G. Garweg
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Pharmaceuticals
Subjects:
diabetic macular edema
intravitreal dexamethasone implant
anti-VEGF
Online Access:https://www.mdpi.com/1424-8247/17/9/1235

Internet

https://www.mdpi.com/1424-8247/17/9/1235

Similar Items